Distinct Molecular Pathways Mediate Progesterone-Induced Growth Inhibition and Focal Adhesion

Endocrinology

Volumn 144, Issue 12, 2003, Pages 5650-5657

  Lin, Valerie C L ^a,b   Woon, Chow Thai ^a   Aw, Swee Eng ^a   Guo, Chunhua ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTINEOPLASTIC AGENT; CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN P21; PROTEIN P42;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME PHOSPHORYLATION; FOCAL ADHESION; GENETIC TRANSFECTION; GROWTH INHIBITION; HORMONE ACTION; HUMAN; HUMAN CELL; MITOSIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTIBODIES; ANTIGENS, CD29; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CYCLIN A; CYCLIN B; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; FLAVONOIDS; FOCAL ADHESIONS; HUMANS; MAP KINASE KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROGESTERONE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; TRANSFECTION; UP-REGULATION;

EID: 0344394221     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0484     Document Type: Article

References (38)

1. Graham JD, Clarke CL 1997 Physiological action of progesterone in target tissues. Endocr Rev 18:502-519
2. Clarke CL, Sutherland RL 1990 Progestin regulation of cellular proliferation. Endocr Rev 11:266-301
3. Sutherland RL, Prall OWJ, Watts CKW, Musgrove EA 1998 Estrogen and progestin regulation of cell cycle progession. J Mammary Gland Biol Neoplasia 3:63-72
4. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery Jr CA, Shyamala G, Conneely OM, O'Malley BW 1995 Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9:2266-2278
5. Sutherland RL, Hall RE, Pang GYN, Musgrove EA, Clarke CL 1988 Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics in human mammary carcinoma cells. Cancer Res 48:5084-5091
6. Van der Burg B, Kalhoven E, Isbrücker L, de Laat SW 1992 Effects of progestins on the proliferation of estrogen-dependent human breast cancer cells under growth factor-defined conditions. J Steroid Biochem Mol Biol 42:457-465
7. Schoonen WG, Joosten JW, Kloosterboer HJ 1995 Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines. J Steroid Biochem Mol Biol 55:439-444
8. Jeng M-H, Parker CJ, Jordan VC 1992 Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Cancer Res 52:6539-6546
9. Kalkhoven E, Kwakkenbos-Isbrücker L, de Laat SW, Van der Saag PT, Van der Burg B 1994 Synthetic progestins induce proliferation of breast tumor cell lines via the progesterone or estrogen receptor. Mol Cell Endocrinol 102:45-52
10. Schoonen WG, Joosten JW, Kloosterboer HJ 1995 Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: 1. MCF-7 cell lines. J Steroid Biochem Mol Biol 55:423-437
11. Going JJ, Anderson TJ, Battersby S, MacIntyre CC 1988 Proliferarive and secretory activity in human breast during natural and artificial menstrual cycles. Am J Pathol 130:193-204
12. Veronesi U, Luini A, Mariani L, Del Vecchio M, Alvez D, Andreoli C, Giacobone A, Merson M, Pacetti G, Raselli R, Saccozzi R 1994 Effect of menstrual phase on surgical treatment of breast cancer. Lancet 343:1545-1547
13. Katzenellenbogen BS 2000 Mechanisms of action and cross-talk between estrogen receptor and progesterone receptor pathways. J Soc Gynecol Invest 7:333-37
14. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, Gong W, Beato M, Auricchio F 1998 Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 17:2008-2018
15. Wen DX, Xu YF, Mais DE, Goldman ME, McDonnelle DP 1994 The A and B isoforms of human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 14:8356-8364
16. Tung L, Mohamed KM, Hoeffler JP, Takimoto GS, Horwitz KB 1993 Antagonist occupied human progesterone B-receptors activate transcription without binding to progesterone response elements, and are dominantly inhibited by A-receptors. Mol Endocrinol 7:1256-1265
17. Gao J, Mazella J, Tang M, Tseng L 2000 Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stroma cells. Mol Endocrinol 14:1954-1961
18. Mulac-Jericevic B, Mullinax RA, DeMayo FJ, Lydon JP, Conneely OM 2001 Subgroup of reproductive functions of progesterone mediated by progesterone receptor B isoform. Science 289:1751-1754
19. Musgrove EA, Lee CS, Sutherland RL 1991 Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos, and c-myc genes. Mol Cell Biol 11:5032-5043
20. Groshong SD, Owen GI, Grimison B, Schauer IE, Todd MC, Langan TA, Sclafani RA, Lange A, Horwitz KB 1997 Biphasic regulation of breast cancer cell growth by progesterone: role of the cyclin-dependent kinase inhibitors, p21 and p27Kip1 Mol Endocrinol 11:1593-1607
21. Musgrove EA, Swarbrick A, Lee CS, Cornish AL, Sutherland RL 1998 Mechanisms of cyclin-dependent kinase inactivation by progestins. Mol Cell Biol 18:1812-1825
22. Lange CA, Richer JK, Chen TJ, Horwitz KB 1998 Convergence of progesterone and epidermal growth factor signaling in breast cancer. J Biol Chem 273: 31308-31316
23. Lange CA, Richer JK, Horwitz KB 1999 Hypothesis: progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals. Mol Endocrinol 13:829-836
24. Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT, Edwards DP 2001 Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell 8:269-280
25. Lin VCL, Ng EH, Aw SE, Tan MG-K, Ng EH-L, Chan VS-W, Ho GH 1999 Progestins inhibit the growth of MDA-MB-231 cells transfected with progesterone receptor cDNA. Clin Cancer Res 5:395-404
26. Lin VCL, Aw SE, Ng EH, Ng EH-L, Chowdhury SH 2001 Effect of progesterone on the invasive properties and tumor growth of progesterone receptor (PR)-transfected breast cancer cells MDA-MB-231. Clin Cancer Res 7:2880-2886
27. Lin VCL, Ng EH, Aw SE, Tan MG-K, Ng EH-L, Bay BH 2000 Progesterone induces cell spreading and focal adhesion in breast cancer cells MDA-MB-231 transfected with progesterone receptor cDNA. Mol Endocrinol 14:348-358
28. Kastner P, Bocquel M-T, Turcotte B, Garnier J-M, Horwitz KB, Chambon P, Gronemeyer H 1990 Transient expression of human and chicken progesterone receptors does not support alternative translational initiation from a single mRNA as the mechanism generating two receptor isoforms. J Biol Chem 265:12163-12167
29. Vindelov LL, Christensen IJ, Nissen NIA 1983 Detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3:323-327
30. Roovers K, Davey G, Zhu X, Bottazzi ME, Assoian RK 1990 α5β1 Integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. Mol Biol Cell 10:3197-3204
31. Hirsch E, Barberis L, Brancaccio M, Azzolino O, Xu D, Kyriakis JM, Silengo L, Giancotti FG, Tarone G, Fassler R, Altruda F 2002 Defective Rac-mediated proliferation and survival after targeted mutation of the β1-integrin cytodomain. J Cell Biol 29:481-492
32. Howe AK, Aplin AE, Juliano RL 2002 Anchorage-dependent ERK signaling-mechanisms and consequences. Curr Opin Genet Dev 12:30-35
33. Assoian RK, Schwartz MA 2001 Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression. Curr Opin Genet Dev 11:48-53
34. Fiucci G, Ravid D, Reich R, Liscovitch M 2002 Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21:2365-2375
35. Jo M, Thomas KS, Somlyo AV, Somlyo AP, Gonias SL 2002 Cooperativity between the Ras-ERK and Rho-Rho kinase pathways in urokinase-type plasminogen activator-stimulated cell migration. J Biol Chem 277:12479-12485
36. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB 2002 Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277:5209-5218
37. Reese J, Das SK, Paria BC, Lim H, Song H, Matsumoto H, Knudtson KL, DuBois RN, Dey SK 2001 Global gene expression analysis to identify molecular markers of uterine receptivity and embryo implantation. J Biol Chem 276:44137-44145
38. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH 2001 Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536